Literature DB >> 1986018

Abnormal sensitivity to glucose of human islets cultured in a high glucose medium: partial reversibility after an additional culture in a normal glucose medium.

A M Davalli1, C Ricordi, C Socci, S Braghi, F Bertuzzi, B Fattor, V Di Carlo, A E Pontiroli, G Pozza.   

Abstract

In the experimental animal chronic hyperglycemia alters the islet's sensitivity to glucose. In the present study the glucose sensitivity of human pancreatic islets, isolated and purified, obtained from seven human pancreases using an automated method was evaluated. After a 12-h stabilization period, islets were cultured for 48 h in normal (5.5 mmol/L) or high glucose (16.7 mmol/L) medium. Islets were then perifused to study their insulin response to glucose. Islets cultured in the high glucose medium lost glucose-induced insulin release and, when challenged with an acute fall of glucose concentration in the perifusate, showed a paradoxical insulin release. Insulin release in response to 10 mmol/L L-arginine was preserved in these islets, suggesting a selective reduction of the insulin response to glucose. An additional 48-h culture in 5.5 mmol/L glucose medium partially restored the sensitivity to glucose of the previously unresponsive islets. These findings indicate that short term exposure to high glucose concentrations induces a selective glucose insensitivity of human islets, which can be partially reversed by an additional culture in normal glucose medium.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1986018     DOI: 10.1210/jcem-72-1-202

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  13 in total

1.  Differentiation of glucose toxicity from beta cell exhaustion during the evolution of defective insulin gene expression in the pancreatic islet cell line, HIT-T15.

Authors:  A Moran; H J Zhang; L K Olson; J S Harmon; V Poitout; R P Robertson
Journal:  J Clin Invest       Date:  1997-02-01       Impact factor: 14.808

2.  Impairment of glucose-induced insulin secretion in human pancreatic islets transplanted to diabetic nude mice.

Authors:  L Jansson; D L Eizirik; D G Pipeleers; L A Borg; C Hellerström; A Andersson
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

Review 3.  Pancreatic Islet Transplantation in Humans: Recent Progress and Future Directions.

Authors:  Michael R Rickels; R Paul Robertson
Journal:  Endocr Rev       Date:  2019-04-01       Impact factor: 19.871

Review 4.  Recovery of endocrine function after islet and pancreas transplantation.

Authors:  Michael R Rickels
Journal:  Curr Diab Rep       Date:  2012-10       Impact factor: 4.810

5.  Multiple chromatin-bound protein kinases assemble factors that regulate insulin gene transcription.

Authors:  Michael C Lawrence; Chunli Shao; Kathleen McGlynn; Bashoo Naziruddin; Marlon F Levy; Melanie H Cobb
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-16       Impact factor: 11.205

6.  Enzymatic, metabolic and secretory patterns in human islets of type 2 (non-insulin-dependent) diabetic patients.

Authors:  J Fernandez-Alvarez; I Conget; J Rasschaert; A Sener; R Gomis; W J Malaisse
Journal:  Diabetologia       Date:  1994-02       Impact factor: 10.122

7.  Prolonged exposure of human pancreatic islets to high glucose concentrations in vitro impairs the beta-cell function.

Authors:  D L Eizirik; G S Korbutt; C Hellerström
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

Review 8.  Clinical islet cell transplantation. Are we there yet?

Authors:  L Rosenberg
Journal:  Int J Pancreatol       Date:  1998-12

9.  Fresh human islet transplantation to replace pancreatic endocrine function in type 1 diabetic patients. Report of six cases.

Authors:  C Socci; L Falqui; A M Davalli; C Ricordi; S Braghi; F Bertuzzi; P Maffi; A Secchi; F Gavazzi; M Freschi
Journal:  Acta Diabetol       Date:  1991       Impact factor: 4.280

10.  The effect of prednisone on pancreatic islet autografts in dogs.

Authors:  Y Zeng; C Ricordi; J Lendoire; P B Carroll; R Alejandro; D R Bereiter; A Tzakis; T E Starzl
Journal:  Surgery       Date:  1993-01       Impact factor: 3.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.